Anika Therapeutics reported $39.54M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbott ABT:US $ 10928M 705M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Acorda Therapeutics ACOR:US $ 31.46M 0.33M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Agenus AGEN:US $ 252.95M 242.22M
Anika Therapeutics ANIK:US $ 39.54M 1.39M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Chemocentryx CCXI:US $ 17.74M 15.93M
Clovis Oncology CLVS:US $ 37.92M 1.1M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Enanta Pharmaceuticals ENTA:US $ 23.58M 1.95M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Immunogen IMGN:US $ 9.21M 7.74M
Insmed INSM:US $ 46.76M 1.39M
Integra Lifesciences IART:US $ 386.86M 3.13M
Intrexon XON:US $ 21.56M 12.02M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Ligand Pharmaceuticals LGND:US $ 64.83M 19.84M
Macrogenics MGNX:US $ 15.66M 15.1M
Merit Medical Systems MMSI:US $ 267.02M 13.3M
Peregrine Pharmaceuticals PPHM:US $ 30.75M 3.15M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Stryker SYK:US $ 4160M 134M
Surmodics SRDX:US $ 23.97M 0.1M
Veracyte VCYT:US $ 60.37M 5.26M
Xencor XNCR:US $ 19.68M 47.76M
Zimmer Biomet Holdings Inc ZBH:US $ 1.92B 102.9M